Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC

Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patientsПодробнее

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of MIBC patientsПодробнее

NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invas...Подробнее

Gemcitabine, cisplatin, and nab-paclitaxel in advanced biliary tract cancersПодробнее

BLASST-1: nivolumab + gemcitabine-cisplatin before radical cystectomy in muscle-invasive BCПодробнее

Nivolumab plus ipilimumab shows clinical benefit as first-line treatment for centrally confirmed...Подробнее

BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle...Подробнее

CheckMate 901: nivolumab with gemcitabine-cisplatin in urothelial carcinomaПодробнее

HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder s...Подробнее

Comment: Nivolumab plus ipilimumab combination for advanced NSCLCПодробнее

A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinomaПодробнее

Gemcitabine, Cisplatin, and Nab-paclitaxel in Advanced Biliary Tract CancerПодробнее

KEYNOTE-966: pembrolizumab, gemcitabine and cisplatin for CCAПодробнее

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancerПодробнее

Neoadjuvant Chemotherapy Plus Nivolumab and BMS-986205 for Muscle Invasive Bladder CancerПодробнее

Borealis-1™: Phase 2 trial of gemcitabine/cisplatin plus apatorsen in advanced bladder cancerПодробнее

A Study of Nivolumab With Nab-Paclitaxel Plus Gemcitabine in Pancreatic CancerПодробнее

Ipilimumab plus nivolumab with sacituzumab govitecan in mUCПодробнее

Nivolumab, Gemcitabine & Cisplatin for Patients w Muscle-Invasive Bladder Cancer Undergo CystectomyПодробнее